Investigation of interleukin-6 (IL-6), soluble IL-6 receptor (sIL-6R) and soluble gp130 (sgp130) in sera of cancer patients

This publication has 23 references indexed in Scilit:

• Relationship of serum levels of interleukin-6, soluble interleukin-6 receptor and tumour necrosis factor receptors to the acute-phase protein response in advanced pancreatic cancer
  Clinical Science, 1999
• CHANGES IN sIL-6R AND sTNF-Rs RELEASE BY PMNs AND THE SERUM LEVELS IN BREAST CANCER PATIENTS AT DIFFERENT STAGES OF TREATMENT
  Cytokine, 1998
• Major role of the soluble interleukin‐6/interleukin‐6 receptor complex for the proliferation of interleukin‐6‐dependent human myeloma cell lines
  European Journal of Immunology, 1997
• Soluble interleukin‐6 receptor (sIL‐6R), a new prognostic factor in multiple myeloma
  British Journal of Haematology, 1996
• Detection of membrane and soluble interleukin‐6 receptor in lymphoid malignancies
  British Journal of Haematology, 1995
• Soluble interleukin-6 receptors in inflammatory bowel disease: relation to circulating interleukin-6.
  Gut, 1995
• Serum levels of interleukin-6 in multiple myeloma and other hematological disorders: correlation with disease activity and other prognostic parameters
  Annals of Hematology, 1991
• Elevated Circulating Interleukin-6 Is Associated with an Acute-phase Response but Reduced Fixed Hepatic Protein Synthesis in Patients with Cancer
  Annals of Surgery, 1991
• Molecular cloning and expression of an IL-6 signal transducer, gp130
  Cell, 1990
• Cloning and Expression of the Human Interleukin-6 (BSF-2/IFNβ 2) Receptor
  Science, 1988